RE:RE:RE:RE:FTC blockage of Amgen's US$28 BLN takeover of HorizonMay 17, 2023 - "Thawing of interest in mega-deals would invariably shift consolidation focus to smaller and earlier-stage biotech companies – and more of them," Evercore analysts said in a note.